Second-dose mRNA COVID-19 vaccine safety in patients with immediate reactions after the first dose: A case series
{{output}}
Background: The rates of suspected allergic reactions to the first dose of the coronavirus disease 2019 (COVID-19) mRNA vaccines have been reported to be as high as 2%, with an anaphylaxis incidence up to 2.5 per 10,000 individua... ...
